Document Detail

Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia.
MedLine Citation:
PMID:  16128949     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Inflammatory bowel diseases (IBD) are characterized by an increased risk for venous and arterial thrombosis. Although the pathogenetic mechanisms of this predisposition are unclear, a possible role of inherited risk factors for thrombosis in determining this predisposition has been suggested. AIM: To evaluate the role of factor V Leiden (G1691A) and G20210A prothrombin gene mutations in determining the occurrence of thrombosis in IBD patients. PATIENTS AND METHODS: Forty-seven IBD patients (30 ulcerative colitis and 17 Crohn's disease) with a positive history for thrombosis (9 at arterial sites and 38 at venous sites) were enrolled in the study. For each patient, two non-IBD subjects matched for sex and age, type, and site of thrombosis were used as controls. Peripheral blood DNA specimens were amplified by PCR using appropriate primers and analyzed by restriction analysis on agarose gel electrophoresis. Statistical analysis was performed by means of Fisher's exact test. RESULTS: The total number of subjects with one or both mutations was significantly lower in IBD patients with thrombosis than in control subjects (12.8%vs 29.8%, respectively; p= 0.035, OR = 0.34, 95% CI 0.13-0.90). The total frequency of the mutated alleles was also significantly lower in IBD than in controls (7.4%vs 16.5%, respectively; p= 0.041, OR = 0.40, 95% CI 0.17-0.96). Prothrombotic mutations were particularly unfrequent in IBD patients with active disease at the time of thrombosis compared with patients with quiescent disease (8.0%vs 36.4%, respectively; p= 0.057, OR = 0.15, 95% CI 0.02-1.01). CONCLUSIONS: The major inherited risk factors for thrombosis are significantly less frequent in thrombotic IBD patients than in thrombotic non-IBD subjects, suggesting that acquired risk factors play the most relevant role in determining thromboembolic events observed in IBD patients, particularly during active phases of the disease.
Luisa Spina; Simone Saibeni; Tullia Battaglioli; Flora Peyvandi; Roberto de Franchis; Maurizio Vecchi
Related Documents :
18285539 - Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic...
6208389 - Abnormal plasminogen: a genetically determined cause of hypercoagulability.
9716579 - Heparin-induced thrombocytopenia: new insights into the impact of the fcgammariia-r-h13...
10990549 - Upper extremity deep venous thrombosis: an underrecognized manifestation of a hypercoag...
14687149 - Venous thromboembolism in inflammatory bowel disease.
20814149 - Prevalence of central vein stenosis following catheterization in patients with end-stag...
2550959 - Patterns of endocrine secretion during sepsis.
17447379 - The pattern of glaucoma in menelik ii hospital addis ababa, ethiopia.
18080769 - The relationship between severity of liver cirrhosis and pulmonary function tests.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of gastroenterology     Volume:  100     ISSN:  0002-9270     ISO Abbreviation:  Am. J. Gastroenterol.     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-08-30     Completed Date:  2005-11-07     Revised Date:  2006-03-16    
Medline Journal Info:
Nlm Unique ID:  0421030     Medline TA:  Am J Gastroenterol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2036-41     Citation Subset:  IM    
Gastroenterology and Gastrointestinal Endoscopy Service, Hepatology Unit, IRCCS Maggiore Hospital, Mangiagalli, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Colitis, Ulcerative / complications
Crohn Disease / complications
Factor V / genetics*
Inflammatory Bowel Diseases / complications*
Middle Aged
Nucleic Acid Amplification Techniques
Prothrombin / genetics*
Risk Factors
Thrombophilia / genetics*
Thrombosis / etiology*,  genetics
Reg. No./Substance:
0/factor V Leiden; 9001-24-5/Factor V; 9001-26-7/Prothrombin
Comment In:
Am J Gastroenterol. 2006 Feb;101(2):403; author reply 403-4   [PMID:  16454851 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease...
Next Document:  Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel dise...